Diseases & Conditions

From acute infections to chronic and rare diseases—risk factors, management, and breakthroughs.

  • 5 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Diseases & Conditions

Infectious Diseases Respiratory, GI, vector‑borne, and antimicrobial resistance trends and care. Chronic Diseases Long‑term conditions: heart, lung, metabolic, kidney, and autoimmune care models. Rare Diseases & Genetics Orphan conditions, registries, gene testing, and family support networks. Pain Management Chronic pain, multimodal strategies, interventional options, and safety concerns. Palliative & Hospice Care Symptom relief, goals of care, and quality of life in serious illness.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Diseases & Conditions


securities.io > evicore-to-cover-guardant-health-shield-colorectal-cancer-blood-test

EviCore to Cover Guardant Health Shield Colorectal Cancer Blood Test

just now   (282+ words) Guardant said the EviCore update extends rapid growth in commercial adoption over its last fiscal quarter, following what it called meaningful coverage expansion from Carelon, which it described as the largest specialty benefits manager in the United States, and UnitedHealth…...


buglenewspapers.com > story > 09/14/2026 > lifestyles > illinois-students-raise-awareness-of-deadly-radon-gas-through-award-winning-creations > 2222.html

Illinois Students Raise Awareness of Deadly Radon Gas Through Award-Winning Creations

3+ hour, 21+ min ago   (126+ words) buglenewspapers.com Illinois Students Raise Awareness of Deadly Radon Gas Through Award-Winning Creations Students win monetary prizes for educating communities about radon, a dangerous, invisible gas found in Illinois homes and schools. CHICAGO – (July 14, 2026) – Local students are being recognized for…...


buffalonews.com > news > nation-world > article_1eec3004-8a2c-4341-9edc-5c330eb05b9b.html

Why mRNA vaccines are giving cancer patients hope

32+ min ago   (187+ words) Buffalo News Javascript is required to use this website. Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead. This story was originally published by PolitiFact. People…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4167979:0-zntl-azenosertib-nears-pivotal-data-in-ovarian-cancer-with-fda-backing-and-robust-financial-runway

ZNTL: Azenosertib nears pivotal data in ovarian cancer, with FDA backing and robust financial runway

42+ min ago   (77+ words) TradingView Azenosertib is advancing in late-stage trials for platinum-resistant ovarian cancer, with strong FDA support and a differentiated safety profile. Expansion into earlier lines and other tumor types is under evaluation, while commercial and financial preparations ensure readiness for upcoming…...


itnonline.com > content > siemens-healthineers-expands-tennessee-molecular-imaging-complex

Siemens Healthineers Expands Tennessee Molecular Imaging Complex

52+ min ago   (529+ words) Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation project at its PET (positron emission tomography) Detector Center in Rockford, Tennessee. The project added 40,000 square feet to the 97,000-square-foot campus and renovated an existing 7,500 square feet of…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4166932:0-nbp-lead-programs-in-oncology-and-ophthalmology-advance-targeting-broader-patient-populations

NBP: Lead programs in oncology and ophthalmology advance, targeting broader patient populations

6+ hour, 56+ min ago   (73+ words) TradingView The discussion highlighted a strategy of sourcing late-stage, de-risked assets globally, with lead programs givastomig and VIS-101 advancing in oncology and ophthalmology. Givastomig shows promise in low claudin expressers and is moving toward phase III, while VIS-101 aims for…...


aad.org > member > advocacy > skin-diseases-ncsp-groups-coalition

Coalition of Skin Diseases and NCSP groups coalition sign on and support

12+ hour, 32+ min ago   (371+ words) Review your profile in our search tool for the public, which helps patients find board-certified dermatologists. Make sure your contact info is up to date in our directory. This listing is for AAD members only. Explore the Academy's new and…...


medpagetoday.com > hematologyoncology > othercancers > 122998

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

1+ hour, 15+ min ago   (31+ words) All responding NCCN members reported shortages, priorities identified but solutions still needed...


medpagetoday.com > dermatology > skincancer > 123001

Photodynamic Therapy for the Most Common Skin Cancer Wins Approval

41+ min ago   (13+ words) Approach for superficial basal cell carcinoma may be ideal for cosmetically sensitive locations...


finance.yahoo.com > healthcare > articles > ataraxis-ai-publishes-landmark-studies-150000013.html

Ataraxis AI Publishes Landmark Studies Showing Causal AI Predicts Chemotherapy Benefit in Multiple Solid Tumors

13+ hour, 32+ min ago   (324+ words) NEW YORK, September 14, 2026--(BUSINESS WIRE)--Ataraxis AI, a company building clinical AI tools to personalize cancer care, today announced scientific breakthroughs and validation results of Ataraxis's AI models. Ataraxis developed breakthrough causal AI methods that learn from large-scale, longitudinal data…...